Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis

References

• Pryce G, O'Neill JK, Croxford JL, Amor S, Hankey DJ, East E, Giovannoni G, Baker D. Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis. J Neuroimmunol. 2005; 165:4–52.
   Google Scholar
• Jackson SJ, Lee J, Nikodemova M, Fabry Z, Duncan ID. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. J Neuropathol Exp Neurol. 2009; 68:616–625.
   Google Scholar
• Jackson SJ, Diemel LT, Pryce G, Baker D. Cannabinoids and neuroprotection in CNS inflammatory disease. J Neurol Sci. 2005; 233:21–25.
   PubMed Web of Science ®Google Scholar
• Baker D, O'Neill JK, Geschmeissner SE, Wilcox CE, Butter C, Turk JL. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol28:261–270.
   Google Scholar
• Hampton DW, . An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. J Neuroimmunol. 2008; 201-202:200–211.
   Google Scholar
• Eikelenboom MJ, . Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology. 2003; 60:219–223.
   PubMed Web of Science ®Google Scholar
• Lim ET, Sellebjerg F, Jensen CV, Altmann DR, Grant D, Keir G, Thompson EJ, Giovannoni G. Acute axonal damage predicts clinical outcome in patients with multiple sclerosis. Mult Scler. 2005; 11:532–536.
   PubMed Web of Science ®Google Scholar
• Petzold A, . Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J Neurol Neurosurg Psychiatry. 2005; 76:206–211.
   PubMed Web of Science ®Google Scholar
• Gunnarsson M, . Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. Ann Neurol. 2011; 69:83–89.
   PubMed Web of Science ®Google Scholar
• Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998; 338:278–285.
   PubMed Web of Science ®Google Scholar
• De Stefano N, . Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol. 2002; 59:1565–1571.
   PubMedGoogle Scholar
• Weiner HL. A shift from adaptive to innate immunity: A potential mechanism of disease progression in multiple sclerosis. J Neurol. 2008; 255:3–11 Suppl 1.
   PubMed Web of Science ®Google Scholar
• Carden MJ, Schlaepfer WW, Lee VM. The structure, biochemical properties, and immunogenicity of neurofilament peripheral regions are determined by phosphorylation state. J Biol Chem. 1985; 260:9805–9817.
   PubMed Web of Science ®Google Scholar
• Pant HC. Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem J. 1988; 256:665–668.
   Google Scholar
• Gurney ME. Transgenic animal models of familial amyotrophic lateral sclerosis. J Neurol. 1997; 244:S15–S20 Suppl 2.
   PubMed Web of Science ®Google Scholar
• Al-Izki S, Pryce G, O'Neill JK, Butter C, Giovannoni G, Amor S, Baker D. Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH Mouse. Mult Scler Rel Dis. 2011; 1:29–38.
   Google Scholar
• Petzold A, Keir G, Green AJ, Giovannoni G, Thompson EJ. A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods. 2003; 278:179–190.
   PubMed Web of Science ®Google Scholar
• Silber E, Semra YK, Gregson NA, Sharief MK. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology. 2002; 58:1372–1381.
   PubMed Web of Science ®Google Scholar
• Kuhle J, . Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology. 2011; 76:1206–1213.
   PubMed Web of Science ®Google Scholar
• Boylan K, Yang C, Crook J, Overstreet K, Heckman M, Wang Y, Borchelt D, Shaw G. Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. J Neurochem. 2009; 111:1182–1191.
   PubMed Web of Science ®Google Scholar
• Ahmed Z, Doward AI, Pryce G, Taylor DL, Pocock JM, Leonard JP, Baker D, Cuzner ML. A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis: inflammation versus degeneration. Am J Pathol. 2002; 161:1577–1586.
   Google Scholar
• Al-Izki S, Pryce G, Jackson SJ, Giovannoni G, Baker D. Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis. Mult Scler. 2011; 17:939–948.
   PubMedGoogle Scholar
• Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem. 2011; 117:528–537.
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy G, . Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med. 2009; 15:626–632.
   PubMed Web of Science ®Google Scholar
• Bartos A, Fialova L, Soukupova J, Kukal J, Malbohan I, Pitha J. Antibodies against light neurofilaments in multiple sclerosis patients. Acta Neurol Scand. 2007; 116:100–107.
   PubMed Web of Science ®Google Scholar
• Bjartmar C, Trapp BD. Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotox Res. 2003; 5:157–164.
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, . Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients. Mult Scler. 2011; 17:830–837.
   PubMedGoogle Scholar
• Talman LS, . Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol. 2010; 67:749–760.
   PubMed Web of Science ®Google Scholar
• Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain. 2006; 129:595–605.
   PubMed Web of Science ®Google Scholar
• Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, Ebers GC. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain. 2010; 133:1914–1929.
   PubMed Web of Science ®Google Scholar